Which has preferable valuation and earnings, HIMS or RDNT?

Hims & Hers Health has higher revenue and earnings than RadNet. Hims & Hers Health is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 3.62 $128.37M -$0.09 N/A RadNet $2.04B 2.65 -$18.65M -$0.18 N/A

Which has better earnings and valuation, RDNT or PACS?

PACS Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.65 -$18.65M -$0.18 N/A PACS Group $5.29B 1.33 $191.54M $1.56 28.59

Is RDNT or PACS more profitable?

PACS Group has a net margin of 4.49% compared to RadNet's net margin of -0.66%. PACS Group's return on equity of 26.47% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% PACS Group 4.49% 26.47% 4.36%

Which has better valuation and earnings, BLLN or RDNT?

Billiontoone has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $354.54M 15.61 $7.45M $0.55 218.82 RadNet $2.04B 2.65 -$18.65M -$0.18 N/A

RadNet (RDNT) Competitors

$68.75 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$68.77 +0.02 (+0.03%)

As of 07/2/2026 05:54 PM Eastern

Compare

RDNT vs. BTSG, FMS, HIMS, PACS, and BLLN

Should you buy RadNet stock or one of its competitors? MarketBeat compares RadNet with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with RadNet include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does RadNet compare to BrightSpring Health Services?

RadNet (NASDAQ:RDNT) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

In the previous week, BrightSpring Health Services had 12 more articles in the media than RadNet. MarketBeat recorded 12 mentions for BrightSpring Health Services and 0 mentions for RadNet. RadNet's average media sentiment score of 1.00 beat BrightSpring Health Services' score of 0.89 indicating that RadNet is being referred to more favorably in the media.

Company	Overall Sentiment
RadNet	Positive
BrightSpring Health Services	Positive

RadNet presently has a consensus price target of $87.43, suggesting a potential upside of 27.17%. BrightSpring Health Services has a consensus price target of $63.67, suggesting a potential downside of 7.77%. Given RadNet's higher possible upside, equities research analysts plainly believe RadNet is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11

BrightSpring Health Services has a net margin of 2.27% compared to RadNet's net margin of -0.66%. BrightSpring Health Services' return on equity of 14.63% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
BrightSpring Health Services	2.27%	14.63%	4.41%

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

RadNet has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.65	-$18.65M	-$0.18	N/A
BrightSpring Health Services	$12.91B	1.05	$190.67M	$1.41	48.96

Summary

BrightSpring Health Services beats RadNet on 11 of the 16 factors compared between the two stocks.

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

RadNet (NASDAQ:RDNT) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

RadNet presently has a consensus price target of $87.43, indicating a potential upside of 27.17%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, indicating a potential upside of 18.92%. Given RadNet's stronger consensus rating and higher possible upside, research analysts clearly believe RadNet is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.65	-$18.65M	-$0.18	N/A
Fresenius Medical Care AG & Co. KGaA	$19.36B	0.66	$1.11B	$1.90	12.39

In the previous week, Fresenius Medical Care AG & Co. KGaA had 2 more articles in the media than RadNet. MarketBeat recorded 2 mentions for Fresenius Medical Care AG & Co. KGaA and 0 mentions for RadNet. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.90 beat RadNet's score of 1.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Overall Sentiment
RadNet	Positive
Fresenius Medical Care AG & Co. KGaA	Very Positive

77.9% of RadNet shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to RadNet's net margin of -0.66%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

RadNet has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

Summary

Fresenius Medical Care AG & Co. KGaA beats RadNet on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Hims & Hers Health has a net margin of -0.56% compared to RadNet's net margin of -0.66%. Hims & Hers Health's return on equity of 6.10% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
RadNet	-0.66%	2.77%	0.97%

Hims & Hers Health has a beta of 2.35, suggesting that its stock price is 135% more volatile than the broader market. Comparatively, RadNet has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market.

Hims & Hers Health presently has a consensus price target of $30.63, indicating a potential downside of 16.64%. RadNet has a consensus price target of $87.43, indicating a potential upside of 27.17%. Given RadNet's stronger consensus rating and higher probable upside, analysts plainly believe RadNet is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, Hims & Hers Health had 11 more articles in the media than RadNet. MarketBeat recorded 11 mentions for Hims & Hers Health and 0 mentions for RadNet. RadNet's average media sentiment score of 1.00 beat Hims & Hers Health's score of 0.77 indicating that RadNet is being referred to more favorably in the news media.

Company	Overall Sentiment
Hims & Hers Health	Positive
RadNet	Positive

Hims & Hers Health has higher revenue and earnings than RadNet. Hims & Hers Health is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.62	$128.37M	-$0.09	N/A
RadNet	$2.04B	2.65	-$18.65M	-$0.18	N/A

Summary

Hims & Hers Health beats RadNet on 10 of the 17 factors compared between the two stocks.

How does RadNet compare to PACS Group?

RadNet (NASDAQ:RDNT) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

PACS Group has a net margin of 4.49% compared to RadNet's net margin of -0.66%. PACS Group's return on equity of 26.47% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
PACS Group	4.49%	26.47%	4.36%

RadNet presently has a consensus price target of $87.43, indicating a potential upside of 27.17%. PACS Group has a consensus price target of $48.00, indicating a potential upside of 7.61%. Given RadNet's stronger consensus rating and higher possible upside, equities analysts plainly believe RadNet is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

PACS Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.65	-$18.65M	-$0.18	N/A
PACS Group	$5.29B	1.33	$191.54M	$1.56	28.59

In the previous week, PACS Group had 3 more articles in the media than RadNet. MarketBeat recorded 3 mentions for PACS Group and 0 mentions for RadNet. RadNet's average media sentiment score of 1.00 beat PACS Group's score of 0.31 indicating that RadNet is being referred to more favorably in the media.

Company	Overall Sentiment
RadNet	Positive
PACS Group	Neutral

RadNet has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Comparatively, 70.1% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

PACS Group beats RadNet on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Billiontoone has a net margin of 0.00% compared to RadNet's net margin of -0.66%. RadNet's return on equity of 2.77% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
RadNet	-0.66%	2.77%	0.97%

Billiontoone has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$354.54M	15.61	$7.45M	$0.55	218.82
RadNet	$2.04B	2.65	-$18.65M	-$0.18	N/A

In the previous week, Billiontoone had 4 more articles in the media than RadNet. MarketBeat recorded 4 mentions for Billiontoone and 0 mentions for RadNet. RadNet's average media sentiment score of 1.00 beat Billiontoone's score of 0.04 indicating that RadNet is being referred to more favorably in the news media.

Company	Overall Sentiment
Billiontoone	Neutral
RadNet	Positive

Billiontoone currently has a consensus price target of $126.00, indicating a potential upside of 4.69%. RadNet has a consensus price target of $87.43, indicating a potential upside of 27.17%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Summary

RadNet beats Billiontoone on 9 of the 15 factors compared between the two stocks.

Get RadNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDNT vs. The Competition

Export

Metric	RadNet	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$5.41B	$6.32B	$7.18B	$12.47B
Dividend Yield	N/A	1.40%	2.66%	6.50%
P/E Ratio	-381.92	41.59	28.02	24.70
Price / Sales	2.65	29.06	532.59	97.92
Price / Cash	21.33	19.39	49.26	57.09
Price / Book	3.91	3.70	10.96	6.46
Net Income	-$18.65M	$218.81M	$3.57B	$337.01M
7 Day Performance	13.19%	5.16%	2.12%	1.69%
1 Month Performance	26.52%	16.16%	5.25%	3.81%
1 Year Performance	22.42%	31.14%	33.29%	23.90%

RadNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDNT RadNet	3.5622 of 5 stars	$68.75 flat	$87.43 +27.2%	+22.4%	$5.41B	$2.04B	N/A	11,264	Positive News Gap Down
BTSG BrightSpring Health Services	3.8272 of 5 stars	$68.98 flat	$61.27 -11.2%	+212.1%	$13.61B	$12.91B	48.92	23,500	News Coverage Analyst Forecast Gap Up
FMS Fresenius Medical Care AG & Co. KGaA	4.5913 of 5 stars	$22.75 -2.1%	$28.00 +23.1%	-16.3%	$12.55B	$22.20B	11.97	1,488
HIMS Hims & Hers Health	2.6366 of 5 stars	$33.36 -1.7%	$29.37 -12.0%	-23.3%	$7.86B	$2.37B	N/A	2,442	Analyst Forecast
PACS PACS Group	2.5421 of 5 stars	$39.94 -4.7%	$48.00 +20.2%	+239.5%	$6.63B	$5.29B	25.60	47,455

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDNT) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RadNet (RDNT) Competitors

RDNT vs. BTSG, FMS, HIMS, PACS, and BLLN

How does RadNet compare to BrightSpring Health Services?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does RadNet compare to Hims & Hers Health?

Summary

How does RadNet compare to PACS Group?

Summary

How does RadNet compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RadNet (RDNT) Competitors

RDNT vs. BTSG, FMS, HIMS, PACS, and BLLN

How does RadNet compare to BrightSpring Health Services?

Does the media refer more to RDNT or BTSG?

Do analysts rate RDNT or BTSG?

Is RDNT or BTSG more profitable?

Do institutionals & insiders have more ownership in RDNT or BTSG?

Which has more risk & volatility, RDNT or BTSG?

Which has better earnings and valuation, RDNT or BTSG?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts recommend RDNT or FMS?

Which has stronger earnings & valuation, RDNT or FMS?

Does the media refer more to RDNT or FMS?

Do institutionals & insiders hold more shares of RDNT or FMS?

Is RDNT or FMS more profitable?

Which has more volatility and risk, RDNT or FMS?

Summary

How does RadNet compare to Hims & Hers Health?

Do institutionals and insiders believe in HIMS or RDNT?

Is HIMS or RDNT more profitable?

Which has more risk and volatility, HIMS or RDNT?

Do analysts rate HIMS or RDNT?

Does the media refer more to HIMS or RDNT?

Which has preferable valuation and earnings, HIMS or RDNT?

Summary

How does RadNet compare to PACS Group?

Is RDNT or PACS more profitable?

Do analysts recommend RDNT or PACS?

Which has better earnings and valuation, RDNT or PACS?

Does the media favor RDNT or PACS?

Which has more risk and volatility, RDNT or PACS?

Do insiders and institutionals believe in RDNT or PACS?

Summary

How does RadNet compare to Billiontoone?

Do insiders & institutionals believe in BLLN or RDNT?

Is BLLN or RDNT more profitable?

Which has better valuation and earnings, BLLN or RDNT?

Does the media prefer BLLN or RDNT?

Do analysts prefer BLLN or RDNT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools